| P50 | author | Daouda Ndiaye | Q28870686 |
| | Dyann Wirth | Q29887904 |
| | Umberto D'Alessandro | Q53680267 |
| | Davis C Nwakanma | Q55175989 |
| | Jean Louis Ndiaye | Q61112866 |
| | Seydou Doumbia | Q87121389 |
| | Ousmane Koita | Q87701854 |
| | Sarah K Volkman | Q89225780 |
| | Ambroise D Ahouidi | Q91932866 |
| | Ayouba Diarra | Q118899504 |
| P2093 | author name string | Tandakha Dieye | |
| | Mamadou Coulibaly | |
| | Muna Affara | |
| | Babacar Mbengue | |
| | Donald J Krogstad | |
| | Rachel Daniels | |
| | Mouhamadou Ndiaye | |
| | Aminata Mbaye | |
| | Awa B Deme | |
| | Baba Dieye | |
| | Ngayo Sy | |
| | Yaye D Ndiaye | |
| | Jules F Gomis | |
| | Lassana Sangare | |
| | Jeffrey Shaffer | |
| | Abubakar Ismaela | |
| | Ahmad Abdullahi | |
| | Alfred Amambua Ngwa | |
| | Clint Welty | |
| | Fatou Joof | |
| | Mouhamadou Diakite | |
| P2860 | cites work | Spread of artemisinin resistance in Plasmodium falciparum malaria | Q21032481 |
| | Antimalarial drug resistance | Q22061790 |
| | Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 |
| | Evidence of Artemisinin-Resistant Malaria in Western Cambodia | Q22061854 |
| | Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial | Q24597403 |
| | Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study | Q24598695 |
| | Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum | Q27861931 |
| | Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance | Q28478286 |
| | A database of antimalarial drug resistance | Q30483123 |
| | Spread of chloroquine resistance in Plasmodium falciparum | Q34355288 |
| | Genetic surveillance detects both clonal and epidemic transmission of malaria following enhanced intervention in Senegal | Q34674130 |
| | Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia | Q35031434 |
| | Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign | Q35594027 |
| | Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children | Q35607844 |
| | Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia | Q35770484 |
| | Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal | Q35891353 |
| | On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey | Q35950930 |
| | Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum | Q36018682 |
| | Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact | Q36080127 |
| | Real-time PCR methods for monitoring antimalarial drug resistance | Q36142600 |
| | Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009. | Q36427202 |
| | Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal | Q36450797 |
| | A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking | Q36976565 |
| | A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya | Q37010425 |
| | Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. | Q37047605 |
| | Blood sample volumes in child health research: review of safe limits | Q37846540 |
| | Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial | Q38397102 |
| | Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum | Q38980049 |
| | The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin | Q38980054 |
| | Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal | Q39228507 |
| | Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. | Q39792488 |
| | Accumulation of CVIET Pfcrt allele of Plasmodium falciparum in placenta of pregnant women living in an urban area of Dakar, Senegal | Q39855998 |
| | Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire | Q40338028 |
| | In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal | Q41917019 |
| | Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal | Q41929191 |
| | In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. | Q41937598 |
| | Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso | Q43932437 |
| | Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 |
| | Malaria transmission dynamics in Niono, Mali: the effect of the irrigation systems | Q44171880 |
| | High spatial resolution mapping of malaria transmission risk in the Gambia, west Africa, using LANDSAT TM satellite imagery | Q44172292 |
| | Artesunate combinations for treatment of malaria: meta-analysis | Q44728450 |
| | How much fat is necessary to optimize lumefantrine oral bioavailability? | Q47824895 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mali | Q912 |
| | The Gambia | Q1005 |
| | Senegal | Q1041 |
| | lumefantrine | Q904464 |
| | drug resistance | Q12147416 |
| | malaria | Q12156 |
| | West Africa | Q4412 |
| P304 | page(s) | 1054-1060 | |
| P577 | publication date | 2016-08-22 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia | |
| P478 | volume | 95 | |